Remission of type 2 diabetes mellitus in patients after different types of bariatric surgery: A population-based cohort study in the United Kingdom

JAMA Surgery

Volumn 150, Issue 12, 2015, Pages 1126-1133

  Yska, Jan Peter ^a   Van Roon, Eric N ^a,b   De Boer, Anthonius ^c   Leufkens, Hubert G M ^c   Wilffert, Bob ^b,d   De Heide, Loek J M ^a   De Vries, Frank ^c,e,f,g   Lalmohamed, Arief ^c,h  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ADVERSE OUTCOME; ARTICLE; BARIATRIC SURGERY; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL RISK; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; FOLLOW UP; GREAT BRITAIN; HEALTH SURVEY; INCIDENCE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OBESITY, MORBID; POSTOPERATIVE CARE; PROCEDURES;

BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; OBESITY, MORBID; POPULATION SURVEILLANCE; POSTOPERATIVE CARE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84950291895     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2015.2398     Document Type: Article

References (30)

1. World Health Organization. Obesity and overweight: fact sheet No. 311. http://www.who.int/mediacentre/factsheets/fs311/en/. Updated January 2015. Accessed March 21, 2015.
2. Leff DR, Heath D. Surgery for obesity in adulthood. BMJ. 2009;339:b3402.
3. Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.
4. Sjöström L, Lindroos AK, Peltonen M, et al; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351(26):2683-2693.
5. Hodo DM, Waller JL, Martindale RG, Fick DM. Medication use after bariatric surgery in a managed care cohort. Surg Obes Relat Dis. 2008;4(5):601-607.
6. Segal JB, Clark JM, Shore AD, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009; 19(12):1646-1656.
7. Crémieux PY, Ledoux S, Clerici C, Cremieux F, Buessing M. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg. 2010;20(7):861-870.
8. Hofsø D, Jenssen T, Hager H, Røislien J, Hjelmesaeth J. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg. 2010;20(3):302-307.
9. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012; 379(9833):2300-2311.
10. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628-642.
11. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323.
12. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21): 2240-2249.
13. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract. 2013;101(1):50-56.
14. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366 (17):1577-1585.
15. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012; 366(17):1567-1576.
16. Schauer PR, Bhatt DL, Kirwan JP, et al; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes. N Engl J Med. 2014;370(21):2002-2013.
17. Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Serné EH, Smulders YM. Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg. 2011;146(6):744-750.
18. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy. 2003;23(5):686-689.
19. Azoulay L, Schneider-Lindner V, Dell'aniello S, Filion KB, Suissa S. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. 2010;19(4):343-350.
20. Eppenga WL, Lalmohamed A, Geerts AF, et al. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care. 2014;37(8):2218-2224.
21. Bazelier MT, de Vries F, Vestergaard P, et al. Risk of fracture with thiazolidinediones: an individual patient data meta-analysis. Front Endocrinol (Lausanne). 2013;4:11.
22. Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ. 2012;345:e5085.
23. Driessen JH, van Onzenoort HA, Henry RM, et al. Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture. Bone. 2014;68:124-130.
24. Diabetes UK. Quality and outcomes framework (QOF) update. https://www.diabetes.org.uk/Documents/About%20Us/Consultations/Quality%20and%20Outcomes%20Framework%20public%20update%202011.pdf. Published 2011. Accessed March 28, 2015.
25. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
26. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256.e5.
27. Puzziferri N, Roshek TB III, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934-942.
28. Burns EM, Naseem H, Bottle A, et al. Introduction of laparoscopic bariatric surgery in England: observational population cohort study. BMJ. 2010;341:c4296.
29. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4): 427-436.
30. Booth H, Khan O, Prevost T, et al. Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. Lancet Diabetes Endocrinol. 2014;2(12):963-968.